Jie Lu Selected Research

Jie Lu Research Topics

Disease

161	Neoplasms (Cancer) 12/2022 - 11/2002
29	Infections 12/2022 - 10/2007
26	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 09/2003
24	Inflammation (Inflammations) 10/2021 - 12/2012
19	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 06/2008
17	Stroke (Strokes) 01/2021 - 03/2007
15	Gout 11/2022 - 05/2015
14	Ischemic Stroke 01/2021 - 05/2008
13	Hypertension (High Blood Pressure) 01/2022 - 01/2004
12	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2011
11	Carcinogenesis 06/2021 - 04/2005
11	Tuberculosis (Tuberculoses) 01/2021 - 04/2013
10	Cognitive Dysfunction 01/2022 - 01/2018
10	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 07/2009
10	Infarction (Infarctions) 01/2020 - 07/2009
9	Glioma (Gliomas) 08/2022 - 08/2010
9	Fibrosis (Cirrhosis) 01/2022 - 11/2009
9	Parkinson Disease (Parkinson's Disease) 01/2022 - 08/2013
9	Wounds and Injuries (Trauma) 12/2021 - 12/2009
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 09/2008
9	Pancreatic Neoplasms (Pancreatic Cancer) 09/2017 - 06/2004
8	Carcinoma (Carcinomatosis) 04/2021 - 12/2007
8	Chronic Hepatitis B 10/2018 - 01/2015
8	Ischemia 01/2017 - 06/2010
8	Starvation 03/2006 - 01/2003
7	Type 2 Diabetes Mellitus (MODY) 01/2021 - 06/2007
7	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2008
7	Reperfusion Injury 10/2017 - 01/2013
7	Hepatitis 01/2016 - 01/2013
7	Melanoma (Melanoma, Malignant) 09/2015 - 05/2011
6	Temporal Lobe Epilepsy 12/2022 - 01/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 01/2017
6	Lung Neoplasms (Lung Cancer) 05/2022 - 03/2009
6	COVID-19 01/2022 - 11/2020
6	Atherosclerosis 10/2021 - 03/2009
6	Liver Neoplasms (Liver Cancer) 08/2021 - 01/2014
6	Lymphoma (Lymphomas) 07/2021 - 07/2009
6	Necrosis 01/2021 - 01/2013
6	AIDS-Related Complex (ARC) 01/2019 - 01/2012
6	Autoimmune Hepatitis 01/2015 - 01/2013

Drug/Important Bio-Agent (IBA)

57	Proteins (Proteins, Gene)FDA Link 03/2022 - 03/2006
39	Pharmaceutical PreparationsIBA 12/2022 - 02/2006
31	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2014
19	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 09/2003
18	CytokinesIBA 01/2021 - 01/2012
14	Uric Acid (Urate)IBA 11/2022 - 05/2015
13	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 03/2006
13	Biological ProductsIBA 02/2022 - 03/2006
13	EnzymesIBA 01/2021 - 05/2009
11	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 06/2009
10	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 09/2003
10	AntibodiesIBA 02/2022 - 01/2013
10	Peptides (Polypeptides)IBA 07/2021 - 01/2010
10	AntigensIBA 01/2021 - 01/2013
10	Messenger RNA (mRNA)IBA 01/2021 - 10/2008
9	Silicon Dioxide (Silica)FDA LinkGeneric 06/2018 - 05/2007
8	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2022 - 04/2005
8	MicroRNAs (MicroRNA)IBA 05/2022 - 10/2009
8	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2004
8	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2016
8	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2004
8	Transcription Factors (Transcription Factor)IBA 01/2022 - 05/2007
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 03/2006
8	Small Interfering RNA (siRNA)IBA 07/2020 - 02/2007
8	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 02/2007
8	Folic Acid (Vitamin M)FDA LinkGeneric 02/2018 - 04/2011
8	Concanavalin AIBA 05/2016 - 01/2013
7	VaccinesIBA 12/2022 - 01/2016
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 09/2003
7	AutoantibodiesIBA 02/2022 - 11/2007
7	LipidsIBA 01/2022 - 01/2016
7	ORALIT (ORS)IBA 01/2022 - 06/2009
7	Therapeutic UsesIBA 01/2022 - 03/2006
7	Apolipoproteins E (ApoE)IBA 11/2021 - 10/2016
7	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2014
7	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2007
7	Angiotensin IIIBA 01/2019 - 03/2013
7	Neuroprotective AgentsIBA 06/2014 - 03/2007
6	LigandsIBA 12/2022 - 04/2005
6	Blood Glucose (Blood Sugar)IBA 01/2022 - 02/2007
6	CholesterolIBA 01/2022 - 03/2011
6	Long Noncoding RNAIBA 01/2022 - 09/2017
6	HDL CholesterolIBA 01/2022 - 01/2004
6	latency-associated nuclear antigenIBA 07/2021 - 07/2009
6	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 07/2008
6	palmidrolIBA 03/2021 - 08/2014
6	CateninsIBA 01/2021 - 01/2013
6	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2020 - 04/2014
6	InterferonsIBA 10/2018 - 03/2011
6	ChromatinIBA 01/2016 - 10/2009
6	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 07/2015 - 07/2009
6	Polysaccharides (Glycans)IBA 09/2014 - 05/2011

Therapy/Procedure

89	Therapeutics 11/2022 - 11/2002
28	Radiotherapy 01/2022 - 12/2007
17	Drug Therapy (Chemotherapy) 02/2022 - 07/2009
11	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2021 - 01/2011
8	Photothermal Therapy 12/2021 - 12/2016
8	Immunotherapy 01/2021 - 05/2011
8	Transplantation 11/2018 - 11/2007
7	Precision Medicine 01/2021 - 02/2015